Please assess the completion status of the following clinical trial:

Trial Title: Immunosenescence and Hepatitis B Virus (HBV) Vaccine Efficacy in Chronic Renal Disease Patient

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with an indication of HBV vaccination~* Patient with renal disease, with a creatinine clearance between 15 and 60ml/min~* Patient who have never been vaccinated against HBV~* Patient with negative serology for HBV~* Patient able to understand the reason of the study~* Patient not opposed to the conservation of biological samples for scientific research~Exclusion Criteria:~* Patient infected with Hepatitis B or with history of vaccination against HBV~* Patient suffering from psychotic illness~* Patient with any history of immunosuppressive therapy~* Patient with infectious and/or cancer diseases in evolution

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Chronic Renal Failure (Type: EXPERIMENTAL): Patients with renal failure, with creatinine clearance between 60 and 15 ml/min. A blood sample is achieved at 0, 1, 3 and 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).